This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.64% per year. These returns cover a period from January 1, 1988 through August 4, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
Stratasys (SSYS) Q4 Earnings and Revenues Beat Estimates
by Zacks Equity Research
Stratasys (SSYS) delivered earnings and revenue surprises of 9.09% and 0.70%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the stock?
Design and Build Your Portfolio With Top 3D Printing Stocks
by Madhurima Das
The future of 3D Printing is supported by its edge over traditional manufacturing and rising adoption. GE, CRS and PRLB will likely ride on this trend.
Zacks Industry Outlook Logitech, Mercury Systems, Stratasys and TransAct
by Zacks Equity Research
Logitech, Mercury Systems, Stratasys and TransAct have been highlighted in this Industry Outlook article.
4 Computer Peripheral Stocks to Watch Amid Industry Woes
by Anirudha Bhagat
Despite a challenging macroeconomic environment, few companies in the Zacks Computer-Peripheral Equipment industry, including LOGI, MRCY, SSYS and TACT, are worth watching due to their end-market strength.
All You Need to Know About Stratasys (SSYS) Rating Upgrade to Strong Buy
by Zacks Equity Research
Stratasys (SSYS) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).
Here's Why SSYS is a Must-Buy Stock Despite 35% Dip in a Year
by Zacks Equity Research
Stratasys' cutting-edge innovations and growth in high-demand industries make the stock a compelling buy.
4 Tech Stocks Under $10 to Add to Your Portfolio in 2025
by Anirudha Bhagat
Here are four under-$10 tech stocks, SSYS, PHUN, BMBL and VTEX, which are poised for growth in 2025, driven by AI, cloud computing and industry innovation.
Stratasys (SSYS) Up 12.3% Since Last Earnings Report: Can It Continue?
by Zacks Equity Research
Stratasys (SSYS) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Stratasys' Q3 Earnings Beat Estimates, Revenues Fall Y/Y
by Zacks Equity Research
SSYS' third-quarter results reflect the negative impacts of the current macroeconomic environment on customer capital equipment spending.
Stratasys (SSYS) Tops Q3 Earnings Estimates
by Zacks Equity Research
Stratasys (SSYS) delivered earnings and revenue surprises of 150% and 3.08%, respectively, for the quarter ended September 2024. Do the numbers hold clues to what lies ahead for the stock?
Cutera (CUTR) Reports Q3 Loss, Misses Revenue Estimates
by Zacks Equity Research
Cutera (CUTR) delivered earnings and revenue surprises of -92.71% and 0.20%, respectively, for the quarter ended September 2024. Do the numbers hold clues to what lies ahead for the stock?
Strength Seen in Stratasys (SSYS): Can Its 9.9% Jump Turn into More Strength?
by Zacks Equity Research
Stratasys (SSYS) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
Stratasys Down 48% YTD: Right Time for Investors to Exit the Stock?
by Zacks Equity Research
SSYS revenues suffer due to high interest rates, macroeconomic uncertainties and reduced capital equipment spending.
SSYS Q2 Revenues Miss: Will FY24 Outlook Drag Shares Down?
by Zacks Equity Research
Stratasys' second-quarter results reflect the negative impacts of divestitures and unfavorable currency exchange rates.
Stratasys (SSYS) Reports Q2 Loss, Lags Revenue Estimates
by Zacks Equity Research
Stratasys (SSYS) delivered earnings and revenue surprises of 0% and 6.78%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?
Stratasys Gears Up to Report Q2 Earnings: Key Factors to Note
by Zacks Equity Research
Forex headwinds and divestment of certain businesses are likely to have hurt SSYS' Q2 top line despite product updates and launches.
CollPlant (CLGN), Stratasys Initiate Study for Breast Implants
by Zacks Equity Research
CollPlant (CLGN) and Stratasys announce the initiation of a pre-clinical study to focus on the ability of implants to grow natural breast tissue and completely degrade over time.
Immersion (IMMR) Q2 Earnings and Revenues Surpass Estimates
by Zacks Equity Research
Immersion (IMMR) delivered earnings and revenue surprises of 78% and 1,263.84%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?
TransAct Technologies Incorporated (TACT) Reports Q2 Loss, Tops Revenue Estimates
by Zacks Equity Research
TransAct Technologies (TACT) delivered earnings and revenue surprises of 82.35% and 13.16%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?
Implied Volatility Surging for Stratasys (SSYS) Stock Options
by Zacks Equity Research
Investors need to pay close attention to Stratasys (SSYS) stock based on the movements in the options market lately.
Stratasys (SSYS) Launches New Dental 3D Printer DentaJet XL
by Zacks Equity Research
Stratasys (SSYS) launches the latest dental 3D printer, DentaJet XL, to reduce costs and improve dental lab productivity.
Stratasys (SSYS) Down 7% Since Last Earnings Report: Can It Rebound?
by Zacks Equity Research
Stratasys (SSYS) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Stratasys (SSYS) Tests 3D Printed Models in Orthopedic Oncology
by Zacks Equity Research
Stratasys (SSYS) and Ricoh co-sponsor a clinical study comparing the efficacy of 3D-printed models to traditional CT or MRI scanning for bone tumor excision planning.
Stratasys (SSYS), AM Craft to Venture Into the Aviation Industry
by Zacks Equity Research
Stratasys (SSYS) partners with AM Craft to expand the demand for flight-certified 3D printed parts in the aviation industry.
Stratasys (SSYS) Launches Latest J5 Digital Anatomy 3D Printer
by Zacks Equity Research
Stratasys (SSYS) launches its latest J5 Digital Anatomy 3D printer to cater to the growing demand for cost-effective anatomical models.